New Threat of Diabetes Type 2 drugs that are known as SGLT2 Inhibitors such as:

  • Invokana
  • Invokamet
  • Farxiga
  • Xigduo XR
  • Glyxambi
  • Jardiance
  • Synjardy

These are fairly new drugs on the market, as the first one, Invokana, came out in March of 2013 and many of the others within the last year.

There are 5 million prescriptions already AND the drug makers identified these as one of the areas they want to grow the fastest BUT WAIT – because of lack of testing on large groups of people these SGLT2 Inhibitors are causing severe injuries, some deadly.

SGLT2 Inhibitors Linked to Severe Injuries Such As:

  • Diabetic Ketoacidosis – (sometimes within 3 days of taking)
  • Kidney Failure
  • Dialysis
  • Coma
  • Stroke
  • Heart Attack/ Cardio Myopathy
  • Death

If you have taken any of these SGLT2 Inhibitors and had these issues, please call us as soon as possible so we can collect the data and help you monetarily.

Call us today at 1-888-978-0000.